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Abstract Interaction of S100a and S100b with duck gizzard
caldesmon was investigated by means of native gel electrophore-
sis, fluorescent spectroscopy and disulfide crosslinking. Both
isoforms of S100 interact with intact caldesmon and its C-
terminal deletion mutant 606C (residues 606^756) with apparent
Kd of 0.2^0.6 WM thus indicating that the S100-binding site is
located in the C-terminal domain of caldesmon. The single SH
group of duck gizzard caldesmon can be crosslinked to Cys-84 of
the L-chain or to Cys-85 of the K-chain of S100. Crosslinking of
S100 reduces the inhibitory action of caldesmon on actomyosin
ATPase activity. S100 reverses the inhibitory action of intact
caldesmon and its deletion mutants 606C (residues 606^756) and
H9 (residues 669^737) as effectively as calmodulin. S100a has
higher affinity to caldesmon and is more effective than S100b in
reversing caldesmon-induced inhibition of actomyosin ATPase
activity. Although monomeric (calmodulin, troponin C) and
dimeric (S100) Ca-binding proteins have different sizes and
structures they interact with caldesmon in a very similar fashion.
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1. Introduction
Caldesmon is a ubiquitous actin-binding protein involved in
the regulation of smooth muscle contraction, non-muscle mo-
tility and cytoskeleton organization [1,2]. Caldesmon func-
tioning is regulated by Ca2 via Ca-binding proteins. Calmod-
ulin and troponin C containing four Ca-binding sites in a
single polypeptide chain interact with the C-terminal part of
caldesmon and reverse its inhibitory action on actomyosin
ATPase activity [3^5].
Dimeric S100 proteins consist of two identical or di¡erent
polypeptide chains each containing two Ca-binding sites [6].
The unfractionated mixture of brain-speci¢c S100 proteins
consisting of KK (S100ao) and LL (S100b) homodimers and
KL (S100a) heterodimers interacts with caldesmon and re-
verses the inhibitory action of caldesmon on actomyosin AT-
Pase activity [7^9]. Two other members of the S100 family,
smooth muscle-speci¢c caltropin [10] and calcyclin (or
S100A6) [11], also interact with caldesmon. Both caltropin
and calcyclin seem to interact with the C-terminal part of
caldesmon [12,13]. Although these two proteins are very sim-
ilar, caltropin reverses the inhibitory action of caldesmon on
actomyosin ATPase activity [10], whereas calcyclin is com-
pletely ine¡ective [13].
The three-dimensional structure of monomeric (calmodulin
and troponin C) [14] and dimeric (calcyclin, S100b) [15^17]
Ca-binding proteins is signi¢cantly di¡erent. In order to
understand the mechanism of interaction of caldesmon with
monomeric and dimeric Ca-binding proteins we compared the
interaction of smooth muscle caldesmon with homodimeric
(LL) S100b, heterodimeric (KL) S100a and monomeric cal-
modulin. We mapped the sites of caldesmon involved in the
interaction with these Ca-binding proteins and compared their
ability to reverse caldesmon-induced inhibition of actomyosin
ATPase activity.
2. Materials and methods
Duck gizzard caldesmon and duck gizzard tropomyosin were puri-
¢ed as described earlier [18]. Caldesmon mutants 606C and H9 were
obtained by bacterial expression in the pMW172 plasmid/BL21(DE3)
cell system [19,20]. Bovine brain calmodulin was isolated according to
Gopalakrishna and Anderson [21]. Unfractionated mixture of S100
proteins was puri¢ed from bovine brain [22] and separation of
S100a and S100b was achieved by ion-exchange chromatography on
DEAE-Sephadex A-25. The purity of isoforms was checked by a dis-
continuous native gel electrophoresis which was run in the presence of
1 mM EGTA [23] and by recording the UV spectra [22]. Rabbit
skeletal actin and myosin were obtained as described earlier [24]
and were kindly provided by Dr. D.I. Levitsky (A.N. Belosersky In-
stitute of Physicochemical Biology, Moscow State University, Mos-
cow, Russia). The purity of all proteins was determined by SDS-
PAGE [25]. The protein concentration was determined spectrophoto-
metrically using O0:1%1cm;280, values equal to 0.33 for caldesmon, 0.20 for
calmodulin, 0.53 for S100a and 0.19 for S100b. The concentration of
caldesmon mutants was determined using £uorescamine [26].
Interaction of caldesmon and its deletion mutant 606C with Ca-
binding proteins was analyzed by means of native gel electrophoresis
[27]. Fixed amounts of S100 or calmodulin were titrated by caldesmon
(or its deletion mutant 606C) in the presence of 0.2 mM CaCl2 or
2 mM EGTA and the intensity of the band of free calcium-binding
protein was determined by densitometry.
Fluorescent spectroscopy was also used for monitoring the interac-
tion of caldesmon with calmodulin and S100. In this case we analyzed
the e¡ect of Ca-binding proteins on the intrinsic Trp £uorescence of
caldesmon [3,4,28] or their e¡ect on the £uorescence of bimane at-
tached to the single Cys residue of caldesmon. Caldesmon (420 nM) in
10 mM Tris-HCl (pH 7.4) containing 100 mM KCl, 4.2 mM L-mer-
captoethanol was titrated by S100b protein or calmodulin either in the
presence of 0.1 mM CaCl2 or in the presence of 2 mM EGTA. The
£uorescence was excited at 290 nm and recorded at 322 nm. Fluores-
cence spectra were recorded in the range of 320^420 nm on a Hitachi
F-3000 spectro£uorimeter.
Duck gizzard caldesmon containing a single SH group located in a
position analogous to that of Cys-580 of chicken gizzard caldesmon
[5,18] was modi¢ed by monobromobimane (0.7 mol of label per mol
of caldesmon). Caldesmon with a modi¢ed SH group (460 nM) in
50 mM Tris-HCl, pH 7.5, was titrated either by calmodulin or by
S100 protein. The £uorescence was excited at 395 nm and recorded
at 450 nm. Fluorescence spectra of modi¢ed caldesmon in the absence
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and in the presence of excess calcium-binding proteins were recorded
in the range of 440^540 nm on a Hitachi F-3000 spectro£uorimeter.
Oxidation of SH groups of S100b (¢nal concentration 70 WM) was
performed in 50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM CaCl2
by mixing with copper (II)^o-phenanthroline complex (¢nal concen-
tration of copper (II) 1 mM). After incubation for 2 h at 30‡C the
reaction was stopped with 5 mM EGTA and the incubation mixture
was dialyzed against 20 mM Tris-HCl (pH 7.5). Protein composition
of the oxidized sample was analyzed by SDS-PAGE run in the ab-
sence of L-mercaptoethanol.
Formation of the disul¢de-crosslinked S100^caldesmon complex
was performed as follows. S100 (¢nal concentration 2.4 mg/ml) was
dissolved in 10 mM HEPES/KOH (pH 7.0), containing 6 M urea and
56 mM L-mercaptoethanol, and incubated for 1.5 h at 30‡C. After-
wards the protein sample was dialyzed against 10 mM HEPES/KOH
(pH 7.0). SH groups of duck gizzard caldesmon were activated by
incubation of the protein (¢nal concentration 60 WM) with an equi-
molar concentration of DTNB in 10 mM HEPES/KOH (pH 7.0) for
1 h at 30‡C. Activated caldesmon was mixed with reduced S100 pro-
tein (¢nal concentration of both proteins 25 WM) and incubated for 30
min at 30‡C. The incubation mixture contained 0.5 mM CaCl2 or
2 mM EGTA and in some experiments was supplemented by addition
of 100 mM NaCl. The protein composition of the crosslinked mixture
was analyzed by SDS-PAGE run both in the presence and in the
absence of L-mercaptoethanol.
Actomyosin ATPase measurements were performed in 10 mM
PIPES/KOH (pH 7.0), containing 5 mM MgCl2 and 10 or 70 mM
KCl. Unmodi¢ed caldesmon or caldesmon crosslinked to S100 was
added to the incubation mixture containing rabbit skeletal actin and
myosin and duck gizzard tropomyosin. After 5 min preincubation the
reaction was started by addition of ATP to a ¢nal concentration of
5 mM. Incubation was continued for 5^15 min, the reaction was
stopped by addition of 10% TCA and inorganic phosphate was de-
termined by the method of Taussky and Shorr [29]. Under conditions
used the ATPase activity of actomyosin measured in the presence of
70 mM KCl at 37‡C was equal to 1^1.2 Wmol of Pi/min per mg of
myosin; this value was taken to represent 100% activity.
3. Results
The method of native gel electrophoresis was used for ana-
lyzing the interaction of two isoforms of S100 protein with
intact caldesmon. In the presence of calcium addition of cal-
desmon to S100 resulted in a diminution of the intensity of
the band of free S100 (Fig. 1). In the absence of calcium
addition of caldesmon had practically no e¡ect on the inten-
sity of the band of S100 (Fig. 1). Plotting the intensity of the
band of the free S100 against the total concentration of cal-
desmon added we determined the apparent Kd values for the
caldesmon^S100a and caldesmon^S100b complexes. These
values were 0.17 þ 0.02 WM for S100a and 0.50 þ 0.04 WM
for S100b. Both these values are comparable to the corre-
sponding values determined for calmodulin (0.2^0.5 WM)
[5,27] and troponin C (1^3 WM) [5]. Thus, dimeric Ca-binding
proteins (S100a and S100b) interact with caldesmon with af-
¢nity comparable to that of monomeric Ca-binding proteins
(calmodulin and troponin C).
Calmodulin-binding sites are located in the C-terminal part
of caldesmon [1^3], and caltropin also interacts with the C-
terminal 27 kDa fragment of caldesmon [12]. Therefore we
supposed that the S100-binding sites are located in the C-
terminal domain of caldesmon. Using the method of native
gel electrophoresis we found that in the presence of Ca2
titration of S100 with the deletion mutant 606C (residues
606^756 of caldesmon) is accompanied by a decrease in the
intensity of the band of free calcium-binding protein. The
apparent Kd values of the complexes of S100a and S100b
with 606C were 0.077 þ 0.038 WM and 1.11 þ 0.41 WM respec-
tively. These values are comparable with those for intact cal-
desmon and indicate that the main S100-binding site is located
in the C-terminal part (residues 606^756) of caldesmon. S100a
interacts with caldesmon (or its deletion mutant) with higher
a⁄nity than S100b.
The C-terminal domain of caldesmon contains three Trp
residues and binding of calmodulin a¡ects the £uorescent
properties of caldesmon [3,4,26,28]. Since S100 binds to the
C-terminal domain of caldesmon we may expect that this
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Fig. 1. Titration of S100a (9.1 WM) by caldesmon. Titration was
performed either in the presence of 1 mM CaCl2 (1) or in the pres-
ence of 2 mM EGTA (2). The percentage of the calcium-binding
protein remaining unbound is plotted against the total concentration
of caldesmon added.
Fig. 2. Disul¢de crosslinking of S100 to caldesmon. A: Crosslinking
of unfractionated S100 to duck gizzard caldesmon. Caldesmon with
DTNB-activated SH groups (1) or its equimolar mixture with un-
fractionated S100 (2, 3) before (2) or after (3) reduction with excess
mercaptoethanol. Crosslinking of S100a (B) or S100b (C) to duck
gizzard caldesmon. Crosslinking of activated caldesmon (1) with
S100 was performed in the presence of either 0.5 mM CaCl2 (2) or
2 mM EGTA (3). Arrows indicate the positions of the cross-linked
complex (CL) and free caldesmon (CaD).
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interaction will also in£uence the intrinsic Trp £uorescence of
caldesmon. Of the two isoforms of S100 only S100b does not
contain Trp residues and is suitable for £uorescence titration
of caldesmon. Addition of about 5 molar excess S-100b was
not accompanied by any signi¢cant change in the Trp £uo-
rescence of caldesmon, whereas addition of calmodulin re-
sulted in a 10^15 nm blue shift of caldesmon £uorescence
and a 1.6^1.8-fold increase of the intensity of £uorescence at
320 nm. Thus, although S100 interacts with the C-terminal
domain of caldesmon it does not a¡ect the £uorescence of
three Trp residues of caldesmon located in this domain. In
this respect S100 is similar to troponin C [5] and caltropin [12]
which also bind to the C-terminal domain of caldesmon with-
out a¡ecting its £uorescent properties.
Recently published models suggest that the folded domains
3 and 4 of caldesmon are involved in formation of the cal-
modulin-binding site [2,5,26,30]. If the mode of binding of
S100 is similar to that of calmodulin we may suppose that
Cys-580 located in domain 3 of caldesmon will be close to
S100-binding sites. Using duck gizzard caldesmon containing
a single Cys in a position analogous to that of Cys-580 of
chicken gizzard caldesmon [5,18] we analyzed the e¡ect of
S100 on the £uorescence of bimane attached to the Cys resi-
due and the probability of crosslinking of S100 to caldesmon.
When duck gizzard caldesmon modi¢ed by monobromobi-
mane was titrated with calmodulin or an unfractionated mix-
ture of S100 protein we observed a 15^20% increase of the
intensity and 10^15 nm blue shift of the £uorescence maxi-
mum. Under the conditions used S100 induced larger changes
in the spectrum of £uorescence of bimane-labeled caldesmon
than calmodulin. These data indicate that the binding of S100
as well as calmodulin a¡ects the environment of the Cys res-
idue located in domain 3 of caldesmon.
In order to obtain more direct proof of this suggestion we
tried to crosslink caldesmon and S100 via a disul¢de bridge.
Caldesmon with a DTNB-activated SH group was incubated
with an equimolar quantity of preliminary reduced S100 (see
Section 2). Modi¢ed caldesmon moved as a band with Mr 140
kDa (Fig. 2A, lane 1). Addition of the unfractionated mixture
of S100 protein leads to the formation of an additional band
with apparent Mr 155 kDa (Fig. 2A, lane 2). If before electro-
phoresis this sample was reduced by excess mercaptoethanol
the band of 155 kDa completely disappeared with a simulta-
neous increase in the intensity of the band of uncrosslinked
caldesmon (Fig. 2A, lane 3). The molecular weight of the
complex is close to that expected for a 1:1 crosslinked com-
plex of caldesmon (Mr 140 kDa) and a single chain of S100
(Mr 10 kDa). All these data mean that the single Cys residue
of caldesmon may interact and form a disul¢de bond with
either Cys-84 (and/or Cys-68) of the L-chain or Cys-85 of
the K-chain of S100. To determine residues of S100 involved
in the binding with caldesmon we analyzed the crosslinking of
two isoforms of S100 and caldesmon in more detail.
Crosslinking of caldesmon with S100a and S100b was per-
formed at high (10 mM HEPES/KOH plus 100 mM NaCl)
ionic strength in the presence and in the absence of Ca2.
Under the conditions used the crosslinked caldesmon^S100
complex was formed only in the presence of Ca2 (Fig.
2B,C). The portion of caldesmon (V60% of total) crosslinked
to S100a was slightly higher than that crosslinked to S100b
(V40%). S100b is a homodimer of two L-chains and contains
four SH groups (two Cys-68+two Cys-84). S100a is a KL
heterodimer and contains three SH groups (Cys-68 and Cys-
84 of the L-chain+Cys-85 of the K-chain). Since the probabil-
ity of crosslinking of S100a was larger than that of S100b we
may conclude that Cys-84 (or 85) rather than Cys-68 is in-
volved in the crosslinking with caldesmon.
It was important to determine whether the binding of S100
a¡ects the ability of caldesmon to inhibit actomyosin ATPase
activity. Under the conditions used addition of caldesmon up
to a molar ratio of actin:caldesmon equal to 10:1 to 8:1
reduced the ATPase activity by 75^80%. The inhibitory e¡ect
of caldesmon was reversed by addition of calcium-binding
proteins. In the presence of 1 mM CaCl2 addition of a 5-
fold molar excess of calmodulin or S100a over caldesmon
completely reversed the inhibitory action of caldesmon (Fig.
3). S100b was less e¡ective than S100a and was unable to
reverse the inhibitory action even after addition of 18 molar
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Fig. 4. E¡ect of non-reduced (1) and reduced (2) crosslinked caldes-
mon^S100 complex on the ATPase activity of actomyosin. Condi-
tions: 10 mM HEPES/KOH, pH 7.0, 10 mM KCl, 5 mM MgCl2,
5 mM ATP, 0.5 mM CaCl2, 30‡C. Protein concentrations (WM): ac-
tin, 0.68; tropomyosin, 0.6; myosin, 0.68. ATPase is expressed as a
percentage of that in the absence of caldesmon.
Fig. 3. Reversion of caldesmon-induced inhibition of actomyosin
ATPase by S100a (1), calmodulin (2), S100b (3) and oxidized S100b
(4). Conditions: 10 mM HEPES/KOH, pH 7.0, 70 mM KCl, 5 mM
MgCl2, 5 mM ATP, 0.5 mM CaCl2, 37‡C. Protein concentrations
(WM): actin, 3.1; tropomyosin 0.6; myosin, 0.7; caldesmon 0.35.
Caldesmon inhibits ATPase activity of actomyosin up to 18%;
100% corresponds to the activity in the absence of caldesmon.
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excess over caldesmon (Fig. 3). In the presence of 1 mM
EGTA neither calmodulin nor two isoforms of S100 reversed
caldesmon-induced inhibition of actomyosin ATPase. The
lower e¡ectivity of S100b can be at least partly due to the
lower a⁄nity of this isoform to caldesmon.
S100b undergoes oxidation and forms oligomers both in
vivo [31] and in vitro [32]. Under the conditions used in our
experiments oxidation results in the formation of a number of
oligomers. According to the data of native gel electrophoresis
oxidized monomers and dimers comprising more than half of
the protein in the oxidized sample practically do not interact
with caldesmon (data not shown). Therefore the oxidized
preparation of S100b was less e¡ective than S100b in revers-
ing the inhibitory e¡ect of caldesmon on actomyosin ATPase
(Fig. 3).
The data presented indicate that the reversible Ca-depend-
ent interaction with S100 prevents the inhibition induced by
caldesmon. As shown earlier (Fig. 2) caldesmon can be cross-
linked to S100 via a disul¢de bond. The crosslinked complex
was puri¢ed by ion-exchange chromatography on Q-Sephar-
ose [5] and was analyzed for its ability to inhibit actomyosin
ATPase before and after reduction by excess mercaptoetha-
nol. The non-reduced cross-linked complex was less e¡ective
than the reduced complex in inhibiting actomyosin ATPase
(Fig. 4). This means that covalent crosslinking of S100 to
Cys located in domain 3 of caldesmon decreases the inhibitory
action of caldesmon on actomyosin ATPase activity.
S100 interacts with the 606C deletion mutant of caldesmon
with a⁄nity comparable to that of intact caldesmon. There-
fore we supposed that S100 will reverse the inhibitory action
of 606C on actomyosin ATPase activity. Indeed addition of
unfractionated S100 completely reversed the inhibitory action
of 606C on actomyosin ATPase and half-maximal reversion
was observed at similar concentrations of S100 and calmodu-
lin.
The deletion mutant of caldesmon H9 (residues 669^737)
contains fewer than 70 C-terminal residues of caldesmon (in-
cluding two calmodulin-binding sites B and BP) and inhibits
the ATPase activity of actomyosin [2,3]. Under the conditions
used H9 induced 40^50% inhibition of actomyosin ATPase
activity and this inhibition was completely reversed by addi-
tion of both calmodulin and unfractionated S100 (Fig. 5). The
concentration of S100 needed for half-maximal reversal of
ATPase inhibition was only slightly higher than that of cal-
modulin. These data mean that S100 interacts with a very
short C-terminal caldesmon fragment and successively re-
verses its inhibitory action on actomysin ATPase activity.
4. Discussion
The data presented demonstrate that S-100 interacts with
and reverses the inhibitory action of short C-terminal frag-
ments of caldesmon (606C and H9) in a manner similar to
that of intact caldesmon. Therefore we may conclude that the
main S100-binding sites are located in the C-terminal part of
caldesmon.
It has been found that calmodulin and S100 interact
with sequences of di¡erent primary structure. The
primary structure SSRINEWLTKT around Trp-692 of cal-
desmon resembles RLSLDSWLKR, KINLQDWLLL and
KYLTLDDWLR which were recognized by Ivanenkov et
al. [33] as potential S100-binding sites. S100 reverses the in-
hibitory action of H9 (containing Trp-692) (Fig. 5), thus in-
dicating that the S100-binding sites may be located in the very
C-terminal part of caldesmon (residues 669^737 of chicken
gizzard caldesmon).
Cys-580 of domain 3 is within 1.5 nm of at least one of the
Trps 659, 692 and 722 of domain 4 of caldesmon [3,34]. It has
been shown that Cys-580 of caldesmon can be crosslinked to
calmodulin [35] and troponin C [5]. S100 can also be cross-
linked via its Cys-84 (or 85) to Cys-580 of caldesmon (Fig. 2)
and covalent binding of S100 to caldesmon reduces its inhib-
itory action on the actomyosin ATPase (Fig. 4). These data
indicate that the overall structure of the complex of caldes-
mon with monomeric (calmodulin, troponin C) and dimeric
(S100) Ca-binding proteins is rather similar.
The three-dimensional structure of S100 is signi¢cantly dif-
ferent from that of calmodulin or troponin C. Recently pub-
lished NMR data reveals that apo-S100b has a rather com-
pact globular structure with overall dimensions of about
38U38U30 Aî [16]. At the same time in the crystal form cal-
modulin has a dumbbell-like shape approximately 65 Aî long
with N- and C-terminal globular domains (25U20U20 Aî )
separated by a long central helix [14,36]. In solution residues
78^81 (in the central helix) adopt a non-helical conformation
and the maximal length of calmodulin is reduced by 10^12 Aî
[36]. Even under these conditions the length of the calmodulin
(or the troponin C) molecule (50^55 Aî ) is signi¢cantly larger
than that of S100 (38 Aî ).
Using a £uorescently labeled calmodulin mutant containing
modi¢ed Cys-34 and Cys-110 Mabuchi et al. [37] concluded
that in the complex with caldesmon calmodulin is in an ex-
tended conformation. If this suggestion is correct and caldes-
mon interacts with completely extended calmodulin with a
long axis of 60^65 Aî , then the structure of the caldesmon^
calmodulin complex should be signi¢cantly di¡erent from that
of caldesmon^S100 because the size of S100 is much smaller
(38U38U30 Aî ). At the same time S100 and calmodulin have
similar a⁄nities to caldesmon and both Ca-binding proteins
are equally e¡ective in reversing the inhibitory action of cal-
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Fig. 5. Reversion of inhibition induced by H9 by unfractionated
S100 (1) and calmodulin (2). Conditions: 10 mM HEPES/KOH, pH
7.0, 10 mM KCl, 5 mM MgCl2, 5 mM ATP, 0.5 mM CaCl2, 25‡C.
Protein concentrations (WM): actin, 5.1; tropomyosin, 1.33; myosin,
1.3; H9, 6.2. H9 inhibits the ATPase activity up to 45%; 100% cor-
responds to the activity in the absence of H9.
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desmon on actomyosin ATPase activity. There are three pos-
sible explanations for this discrepancy. (1) Calmodulin inter-
acts with caldesmon in at least a partly bent conformation. (2)
The three-dimensional structure of Ca-saturated S100 (which
is still not resolved) is di¡erent from that of apo-S100 and has
signi¢cantly larger dimensions. (3) The C-terminal domain of
caldesmon is very £exible and can adopt Ca-binding proteins
of a very di¡erent size and di¡erent orientation of the Ca-
binding sites.
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